x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:23:47

Analyst Tuesdays: Mizuho Senior Analyst Graig...

BiotechTV - News ·

2025/03/18

He sets the table for upcoming readouts from Axsome, Vigil Neuro, Verastem, Corvus, and Harmony Biosciences.

en-us

00:17:14

The co-founders of Vevo Therapeutics describe the Arc...

BiotechTV - News ·

2025/03/17

CEO Nima Alidoust and CSO Johnny Yu describe Vevo's contribution of 100M cells, plus a 60,000 drug-patient interaction map, that has been combined with Arc's 200M cell gene expression data from 21 different species (scBaseCamp). They explain the size and scale of this now open source atlas, and the potential utility of it to outside researchers.

en-us

00:11:07

From struggling with sickle cell disease to climbing...

BiotechTV - News ·

2025/03/14

Jimi Olaghere describes how his life has changed after participating in a clinical trial for the CRISPR based gene therapy for sickle cell disease that is now called CASGEVY. He describes what it was like receiving the treatment, and discusses the need for more awareness and access in the sickle cell community worldwide for this type of treatment.

en-us

00:18:30

Bonum Therapeutics aims to lower the toxicity of...

BiotechTV - News ·

2025/03/14

Founder & CEO John Mulligan describes how he and his team sold an asset using the same science to Roche in 2022 for $250 million when they were Good Therapeutics, and how the follow-on company Bonum aims to test this approach more broadly. He describes how it works, and discusses the initial programs they have chosen, with a LAG3-IL2 being the most advanced.

en-us

00:06:16

Alta Partners' Managing Director Bob More shares his...

BiotechTV - News ·

2025/03/14

He discusses the current downturn, they key of being focused, and his preference of investing in people first. Plus, comments on portfolio companies eGenesis and Vir Biotechnology.

en-us

00:05:38

Congratulations to Luke Timmerman on 10 years of...

BiotechTV - News ·

2025/03/14

Celebrating with the Seattle (and beyond) biotech community.

en-us

00:07:04

Tour of Scotland: Glasgow based EnteroBiotix is...

BiotechTV - News ·

2025/03/13

CEO Jame Mcllroy describes the scientific platform and how it contrasts to other microbiome approaches. A trial in IBS is scheduled to read out immanently.

en-us

00:05:46

Tour of Scotland: Scotland's Chief Scientist (Health)...

BiotechTV - News ·

2025/03/13

Professor Dame Anna Dominiczak describes how new technologies are being rolled out in the community equitably, such as digital dermatology, and invites companies to run clinical trials in Scotland.

en-us

00:16:48

HumanX: Generate Biomedicines' CEO Mike Nally...

BiotechTV - News ·

2025/03/13

From the big HumanX AI conference in Las Vegas, he describes the overall path he sees AI taking in its contributions to drug development, and gives an update on Generate's programs regarding TSLP, IL13, ADCs, and more.

en-us

00:05:51

Tour of Scotland: St. Andrews based Pneumagen aims to...

BiotechTV - News ·

2025/03/13

Co-Founder & CEO Douglas Thomson describes how the company was founded, and walks us through the science. Plus, a recap of recently presented phase 2 data, and the road ahead.

en-us

00:05:34

Tour of Scotland: Dundee based Glen Clova Scientific...

BiotechTV - News ·

2025/03/13

CEO Steven Powell joins BiotechTV from Scotland's Life Sciences Conference and Awards in Glasgow, and explains Glen Clova's expertise in making next generation VLPs. The first clinical program will be in senile pruritus, targeting IL-31.

en-us

00:07:20

Tour of Scotland: Mark Cook, Co-Chair of Life...

BiotechTV - News ·

2025/03/13

He describes the assets that Scotland has to offer the industry such as excellent universities that derive innovation and a diverse population that makes it a great region for clinical trials.

en-us

00:07:18

Tour of Scotland: Glasgow based Mironid is developing...

BiotechTV - News ·

2025/03/13

Co-Founder & CEO Neil Wilkie walks us through the biology of ADPKD and explains how Mironid is trying to uniquely directly target it. Plus, the growth of the company, investor support, and being based in Glasgow.

en-us

00:08:43

Tour of Scotland: Vicki Hazley, Associate Director of...

BiotechTV - News ·

2025/03/13

She describes The Bank's goal of supporting life sciences in Scotland and making a societal impact, how it aims to co-invest with likeminded investors. Plus, examples of investments such as Elasmogen and PneumoWave.

en-us

00:18:02

Professor Pieter Cullis and Jay Kulkarni, co-founders...

BiotechTV - News ·

2025/03/12

Professor Cullis, one of the original pioneers of LNPs and co-founder of 11 biotechnology companies, describes the challenge of successfully using lipid nanoparticles to deliver payloads to places outside of the liver. Jay Kulkarni, a former postdoc of his who is co-founder and CSO of the company, describes the 'one-stop-shop' capabilities of NanoVation, which has already led to a partnership with Novo Nordisk and others.

en-us

00:10:31

Tour of Scotland: Edinburgh based Trogenix is...

BiotechTV - News ·

2025/03/12

CEO Ken Macnamara describes the science behind this idea and discusses recently presented preclinical data. He highlights the lead program for glioblastoma and plans for the future, and also explains how he believes a patient sample biobank Trogenix has built is key to the company's success in research.

en-us

00:09:02

Tour of Scotland: A leading investor who is focused...

BiotechTV - News ·

2025/03/12

Andrew McNeill, Managing Partner of St. Andrews based Eos Advisory, introduces us to the firm and some portfolio companies including Dxcover and Laverock Therapeutics.

en-us

00:17:18

Acuitas Therapeutics is a pioneer in developing lipid...

BiotechTV - News ·

2025/03/12

Co-Founder & CEO Thomas Madden describes the science and history behind LNPs, and discusses what is currently in development, including trying to use them to deliver therapies outside of the liver.

en-us

00:09:32

Tour of Scotland: Edinburgh based Cumulus Oncology...

BiotechTV - News ·

2025/03/12

Founder & CEO Clare Wareing describes the company's design, with an eye towards being capital efficient and investing over and again for the long-term. She describes the lead investments: a PARG inhibitor, GPR68 small molecules, and a GTPase inhibitor.

en-us

00:07:59

Tour of Scotland: Outrun Therapeutics is aiming to...

BiotechTV - News ·

2025/03/12

CEO Carolyn Porter describes the beginning of the company, which spun out of University of Dundee's MRC Protein Phosphorylation and Ubiquitylation Unit (PPU). The first goal is to go after hard to treat solid tumors.

en-us

362 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter